Viewing Study NCT04588194


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2026-03-09 @ 7:04 AM
Study NCT ID: NCT04588194
Status: UNKNOWN
Last Update Posted: 2020-10-19
First Post: 2020-01-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia
Sponsor: David Gomez Almaguer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Immune Thrombocytopenia View
None Thrombotic Thrombocytopenic Purpura View
Keywords:

Keywords

Keyword Brief Keyword Text View
None thrombocytopenia View